American Board of Psychiatry and Neurology (ABPN) Practice Exam

The approach of administering flurazepam at bedtime for sleep is not suitable for treating a patient with acute delirium. Delirium is characterized by an acute change in attention and cognition, often linked to underlying medical conditions or substance issues, and can lead to fluctuating levels of consciousness and awareness. Using sedative medications like flurazepam, which is a benzodiazepine, can further impair cognitive function and exacerbate confusion in these patients. Additionally, benzodiazepines can increase the risk of respiratory depression, particularly in the elderly or those with comorbid conditions.

In contrast, options like increasing lighting in the room help to provide orientation and reduce disorientation often associated with delirium. Low-dose haloperidol can be effective in managing severe agitation or psychotic symptoms without significantly worsening cognition. Companionship and family support offer reassurance and a soothing environment, which can alleviate distress and enhance cognitive clarity. Therefore, flurazepam is not an appropriate choice in the management of acute delirium.